EyePoint, Inc. Selling and Marketing Expense
EyePoint, Inc. (EYPT) reported Selling and Marketing Expense of $31.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingAndMarketingExpense · last filed 2026-08-05
- EyePoint, Inc. selling and marketing expense for the quarter ending 2026-06-30 was $31.00K, a 11.43% decline year-over-year.
- EyePoint, Inc. selling and marketing expense for the quarter ending 2026-03-31 was $3.00K, a 91.43% decline year-over-year.
- EyePoint, Inc. selling and marketing expense for the quarter ending 2025-12-31 was -$6.00K, a 111.76% decline year-over-year.
- EyePoint, Inc. selling and marketing expense for the quarter ending 2025-09-30 was $26.00K, a 8.33% increase year-over-year.
- EyePoint, Inc. selling and marketing expense for fiscal 2025 was $90.00K, a 31.30% decline from fiscal 2024.
- EyePoint, Inc. selling and marketing expense for fiscal 2024 was $131.00K, a 98.88% decline from fiscal 2023.
- EyePoint, Inc. selling and marketing expense for fiscal 2023 was $11.69M, a 54.17% decline from fiscal 2022.
- EyePoint, Inc. selling and marketing expense for fiscal 2022 was $25.51M, a 7.26% decline from fiscal 2021.
| Period end | Selling and Marketing Expense 3 month | Selling and Marketing Expense 6 month | Selling and Marketing Expense 9 month | Selling and Marketing Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $31.00K 10-Q · filed 2026-08-05 | $34.00K 10-Q · filed 2026-08-05 | $28.00K derived: sum of 3 quarters · filed 2026-08-05 | $54.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $3.00K 10-Q · filed 2026-05-07 | -$3.00K derived: sum of 2 quarters · filed 2026-05-07 | $23.00K derived: sum of 3 quarters · filed 2026-05-07 | $58.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $20.00K derived: sum of 2 quarters · filed 2026-03-05 | $55.00K derived: sum of 3 quarters · filed 2026-08-05 | $90.00K 10-K · filed 2026-03-05 |
| 2025-09-30 | $26.00K 10-Q · filed 2025-11-06 | $61.00K derived: sum of 2 quarters · filed 2026-08-05 | $96.00K 10-Q · filed 2025-11-06 | $147.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $35.00K 10-Q · filed 2026-08-05 | $70.00K 10-Q · filed 2026-08-05 | $121.00K derived: sum of 3 quarters · filed 2026-08-05 | $145.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $35.00K 10-Q · filed 2026-05-07 | $86.00K derived: sum of 2 quarters · filed 2026-05-07 | $110.00K derived: sum of 3 quarters · filed 2026-05-07 | $160.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $51.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $75.00K derived: sum of 2 quarters · filed 2026-03-05 | $125.00K derived: sum of 3 quarters · filed 2026-03-05 | $131.00K 10-K · filed 2026-03-05 |
| 2024-09-30 | $24.00K 10-Q · filed 2025-11-06 | $74.00K derived: sum of 2 quarters · filed 2025-11-06 | $80.00K 10-Q · filed 2025-11-06 | $265.00K derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $50.00K 10-Q · filed 2025-08-07 | $56.00K 10-Q · filed 2025-08-07 | $241.00K derived: sum of 3 quarters · filed 2025-08-07 | $720.00K derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $6.00K 10-Q · filed 2025-05-08 | $191.00K derived: sum of 2 quarters · filed 2025-05-08 | $670.00K derived: sum of 3 quarters · filed 2025-05-08 | $5.96M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $185.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $664.00K derived: sum of 2 quarters · filed 2025-03-06 | $5.95M derived: sum of 3 quarters · filed 2025-03-06 | $11.69M 10-K · filed 2025-03-06 |
| 2023-09-30 | $479.00K 10-Q · filed 2024-11-07 | $5.77M derived: sum of 2 quarters · filed 2024-11-07 | $11.50M 10-Q · filed 2024-11-07 | $17.42M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $5.29M 10-Q · filed 2024-08-08 | $11.03M 10-Q · filed 2024-08-08 | $16.94M derived: sum of 3 quarters · filed 2024-08-08 | $22.96M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $5.74M 10-Q · filed 2024-05-09 | $11.65M derived: sum of 2 quarters · filed 2024-05-09 | $17.67M derived: sum of 3 quarters · filed 2024-05-09 | $24.55M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $5.92M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | $11.93M derived: sum of 2 quarters · filed 2024-03-08 | $18.81M derived: sum of 3 quarters · filed 2024-03-08 | $25.51M 10-K · filed 2024-03-08 |
| 2022-09-30 | $6.02M 10-Q · filed 2023-11-03 | $12.90M derived: sum of 2 quarters · filed 2023-11-03 | $19.59M 10-Q · filed 2023-11-03 | $27.40M derived: sum of 4 quarters · filed 2023-11-03 |
| 2022-06-30 | $6.88M 10-Q · filed 2023-08-04 | $13.58M 10-Q · filed 2023-08-04 | $21.39M derived: sum of 3 quarters · filed 2023-08-04 | $28.76M derived: sum of 4 quarters · filed 2023-08-04 |
| 2022-03-31 | $6.69M 10-Q · filed 2023-05-04 | $14.50M derived: sum of 2 quarters · filed 2023-05-04 | $21.88M derived: sum of 3 quarters · filed 2023-05-04 | $28.54M derived: sum of 4 quarters · filed 2023-05-04 |
| 2021-12-31 | $7.81M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-10 | $15.19M derived: sum of 2 quarters · filed 2023-03-10 | $21.84M derived: sum of 3 quarters · filed 2023-03-10 | $27.50M 10-K · filed 2023-03-10 |
| 2021-09-30 | $7.37M 10-Q · filed 2022-11-04 | $14.03M derived: sum of 2 quarters · filed 2022-11-04 | $19.69M 10-Q · filed 2022-11-04 | $25.50M derived: sum of 4 quarters · filed 2022-11-04 |
| 2021-06-30 | $6.66M 10-Q · filed 2022-08-05 | $12.32M 10-Q · filed 2022-08-05 | $18.13M derived: sum of 3 quarters · filed 2022-08-05 | $23.40M derived: sum of 4 quarters · filed 2022-08-05 |
| 2021-03-31 | $5.66M 10-Q · filed 2022-05-06 | $11.47M derived: sum of 2 quarters · filed 2022-05-06 | $16.74M derived: sum of 3 quarters · filed 2022-05-06 | $22.83M derived: sum of 4 quarters · filed 2022-05-06 |
| 2020-12-31 | $5.81M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14 | $11.08M derived: sum of 2 quarters · filed 2022-03-14 | $17.17M derived: sum of 3 quarters · filed 2022-03-14 | $25.29M 10-K · filed 2022-03-14 |
| 2020-09-30 | $5.27M 10-Q · filed 2021-11-05 | $11.36M derived: sum of 2 quarters · filed 2021-11-05 | $19.48M 10-Q · filed 2021-11-05 | $26.88M derived: sum of 4 quarters · filed 2021-11-05 |
| 2020-06-30 | $6.09M 10-Q · filed 2021-08-06 | $14.21M 10-Q · filed 2021-08-06 | $21.61M derived: sum of 3 quarters · filed 2021-08-06 | $29.39M derived: sum of 4 quarters · filed 2021-08-06 |
| 2020-03-31 | $8.13M 10-Q · filed 2021-05-05 | $15.52M derived: sum of 2 quarters · filed 2021-05-05 | $23.30M derived: sum of 3 quarters · filed 2021-05-05 | $30.59M derived: sum of 4 quarters · filed 2021-05-05 |
| 2019-12-31 | $7.40M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $15.18M derived: sum of 2 quarters · filed 2021-03-12 | $22.46M derived: sum of 3 quarters · filed 2021-03-12 | $29.77M 10-K · filed 2021-03-12 |
| 2019-09-30 | $7.78M 10-Q · filed 2020-11-06 | $15.06M derived: sum of 2 quarters · filed 2020-11-06 | $22.37M 10-Q · filed 2020-11-06 | $26.90M derived: sum of 4 quarters · filed 2020-11-06 |
| 2019-06-30 | $7.28M 10-Q · filed 2020-08-05 | $14.60M 10-Q · filed 2020-08-05 | $19.12M derived: sum of 3 quarters · filed 2020-08-05 | $22.77M derived: sum of 4 quarters · filed 2020-08-05 |
| 2019-03-31 | $7.31M 10-Q · filed 2020-05-08 | $11.84M derived: sum of 2 quarters · filed 2020-05-08 | $15.48M derived: sum of 3 quarters · filed 2020-05-08 | $17.00M derived: sum of 4 quarters · filed 2020-05-08 |
| 2018-12-31 | $4.53M derived: 10-K 6 month − 10-Q 3 month · filed 2020-03-16 | $8.17M 10-K · filed 2020-03-16 | $9.69M derived: sum of 3 quarters · filed 2020-03-16 | $9.66M 10-K · filed 2020-03-16 |
| 2018-09-30 | $3.65M 10-Q · filed 2019-11-07 | $5.16M derived: sum of 2 quarters · filed 2019-11-07 | $5.16M 10-Q · filed 2019-11-07 | |
| 2018-06-30 | $1.51M 10-Q · filed 2019-08-07 | $1.51M 10-Q · filed 2019-08-07 | $1.51M 10-K · filed 2020-03-16 | |
| 2017-09-30 | $0.00 10-Q · filed 2018-11-09 | |||
| 2017-06-30 | $0.00 10-KT · filed 2019-03-18 | |||
| 2016-06-30 | $0.00 10-KT · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |